ArticleAIDS research and therapy2021

Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS).

Z C Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.